Literature DB >> 22133456

Assessing outcomes to determine whether symptoms related to hypertension justify renal artery stenting.

J Gregory Modrall1, Eric B Rosero, Carlos H Timaran, Thomas Anthony, Jayer Chung, R James Valentine, Clayton Trimmer.   

Abstract

OBJECTIVE: The goal of the study was to determine the blood pressure (BP) response to renal artery stenting (RAS) for patients with hypertension urgency, hypertension emergency, and angina with congestive heart failure (angina/congestive heart failure [CHF]).
METHODS: Patients who underwent RAS for hypertension emergencies (n = 13), hypertension urgencies (n = 25), and angina/CHF (n = 14) were included in the analysis. By convention, hypertension urgency was defined by a sustained systolic BP ≥ 180 mm Hg or diastolic BP ≥ 120 mm Hg, while the definition of hypertension emergency required the same BP parameters plus hypertension-related symptoms prompting hospitalization. Patient-specific response to RAS was defined according to modified American Heart Association reporting guidelines.
RESULTS: The study cohort of 52 patients had a median age of 66 years (interquartile range 58-72). The BP response to RAS varied significantly according to the indication for RAS. Hypertension emergency provided the highest BP response rate (85%), while the response rate was significantly lower for hypertension urgency (52%) and angina/CHF (7%; P = .03). Only 1 of 14 patients with angina/CHF was a BP responder. Multivariate analysis showed that hypertension urgency or emergency were not independent predictors of BP response to RAS. Instead, the only independent predictor of a favorable BP response was the number of preoperative antihypertensive medications (odds ratio 7.5; 95% confidence interval 2.5-22.9; P = .0004), which is another indicator of the severity of hypertension. Angina/CHF was an independent predictor of failure to respond to RAS (odds ratio 118.6; 95% confidence interval 2.8-999.9; P = .013).
CONCLUSIONS: Hypertension urgency and emergency are clinical manifestations of severe hypertension, but the number of preoperative antihypertensive medications proved to be a better predictor of a favorable BP response to RAS. In contrast, angina/CHF was a predictor of failure to respond to stenting, providing further evidence against the practice of incidental stenting during coronary interventions.
Copyright © 2012 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133456     DOI: 10.1016/j.jvs.2011.08.056

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

Review 1.  Renovascular hypertension: is there still a role for stent revascularization?

Authors:  Stephen C Textor
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-09       Impact factor: 2.894

2.  Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension.

Authors:  Ananda T Dias; Bianca P Rodrigues; Marcella L Porto; Agata L Gava; Camille M Balarini; Flavia P S Freitas; Zaira Palomino; Dulce E Casarini; Bianca P Campagnaro; Thiago M C Pereira; Silvana S Meyrelles; Elisardo C Vasquez
Journal:  J Transl Med       Date:  2014-02-06       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.